User talk:Coloneh/Vengeful Remedy Necromancer

Personally I'd switch Life for Signet of Sorrow so as to fully utilize Soul Reaping, and gives you a bit more way to help out the team in kills. Life is nice when you've got more allies, Pets and Minions etc; some untyped damage on the side, though, is always good and non conditional. Plus, it means no target for Spiritual Pain and such. Entropy 00:24, 3 January 2007 (CST)
 * sounds good, iv been using this in RA and life isnt very useful. my last team was very impressed with it, but we only got 5 wins because our sin lagged whille we were fighting this godly 3 derv, 1 IW team.--Coloneh RIP[[Image:Coloneh.png]] 01:03, 3 January 2007 (CST)

I don't really see the point of Necromancer primary (unless this is PvE or AB). I would go Ritualist primary and use Renewing Memories with Generous was Tsungrai. Weapon of Shadow seems kind of counteractive, but if you find it helps the keep it. Skaspaakssa 20:16, 4 January 2007 (CST)
 * necro primary for soul reaping, since you dont need any attributes other than restoration magic. weapon of shadow lets you put it on a meleer once and then use wielder's bood when they need healing so you can focus more on other party members. its not a damage build, thats just a perk.--Coloneh RIP[[Image:Coloneh.png]] 21:50, 4 January 2007 (CST)
 * You wouldn't really benefit too much from SR in the Arenas, but N/x healers are godly in PvE and AB. If you went Rt/x you could take Renewing Memories and Attuned was Songkai for a 'dual attunes' kind of effect, letting you spam just about anything. Tycn 18:55, 3 February 2007 (CST)
 * yeah, its more of a PvE build, but i dont have remedy wep. and for the record, i used this before people started using jagged bones in HA.--Coloneh RIP[[Image:Coloneh.png]] 01:10, 4 February 2007 (CST)

I was tryin a N/rt build similar to this and came across this build. I'd drop life for somethin else, since none of your other spells rely on spirits. There's lots of nice spells in Restoration. P A R A S I T I C 18:15, 12 February 2007 (CST)